Penn Davis McFarland’s Amgen AMGN Stock Holding History

Penn Davis McFarland’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.79M	Sell	18,748 -18	-0.1%	-$6.16K	0.6%	32
2026 Q1	$6.6M	Sell	18,766 -50	-0.3%	-$17.8K	0.65%	32
2025 Q4	$6.16M	Sell	18,816 -15	-0.1%	-$4.76K	0.59%	32
2025 Q3	$5.31M	Hold	18,831	–	–	0.55%	32
2025 Q2	$5.26M	Sell	18,831 -125	-0.7%	-$35.4K	0.59%	31
2025 Q1	$5.91M	Sell	18,956 -72	-0.4%	-$21.3K	0.7%	31
2024 Q4	$4.96M	Sell	19,028 -122	-0.6%	-$36.2K	0.54%	32
2024 Q3	$6.17M	Buy	19,150 +17,650	+1,177%	+$5.77M	0.69%	30
2024 Q2	$469K	Hold	1,500	–	–	0.07%	41
2024 Q1	$426K	Hold	1,500	–	–	0.07%	41
2023 Q4	$432K	Hold	1,500	–	–	0.07%	40
2023 Q3	$403K	Hold	1,500	–	–	0.07%	40
2023 Q2	$333K	Hold	1,500	–	–	0.06%	39
2023 Q1	$363K	Hold	1,500	–	–	0.07%	38
2022 Q4	$394K	Sell	1,500 -34	-2%	-$9.11K	0.08%	39
2022 Q3	$346K	Sell	1,534 -7	-0.5%	-$1.7K	0.07%	37
2022 Q2	$375K	Buy	1,541 +7	+0.5%	+$1.72K	0.07%	38
2022 Q1	$371K	Hold	1,534	–	–	0.06%	41
2021 Q4	$345K	Hold	1,534	–	–	0.06%	41
2021 Q3	$326K	Hold	1,534	–	–	0.06%	41
2021 Q2	$374K	Hold	1,534	–	–	0.07%	37
2021 Q1	$382K	Sell	1,534 -30	-2%	-$7.16K	0.07%	38
2020 Q4	$360K	Hold	1,564	–	–	0.08%	39
2020 Q3	$398K	Hold	1,564	–	–	0.1%	34
2020 Q2	$369K	Hold	1,564	–	–	0.1%	37
2020 Q1	$317K	Hold	1,564	–	–	0.11%	33
2019 Q4	$377K	Buy	1,564 +64	+4%	+$14.1K	0.11%	30
2019 Q3	$290K	Hold	1,500	–	–	0.09%	31
2019 Q2	$276K	Hold	1,500	–	–	0.09%	29
2019 Q1	$285K	Hold	1,500	–	–	0.1%	29
2018 Q4	$292K	Hold	1,500	–	–	0.11%	27
2018 Q3	$311K	Hold	1,500	–	–	0.09%	34
2018 Q2	$277K	Hold	1,500	–	–	0.09%	34
2018 Q1	$256K	Hold	1,500	–	–	0.08%	29
2017 Q4	$261K	Hold	1,500	–	–	0.08%	28
2017 Q3	$280K	Hold	1,500	–	–	0.09%	28
2017 Q2	$258K	Hold	1,500	–	–	0.08%	31
2017 Q1	$246K	Hold	1,500	–	–	0.07%	32
2016 Q4	$219K	Hold	1,500	–	–	0.06%	36
2016 Q3	$250K	Buy	+1,500	New	+$254K	0.06%	37

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Penn Davis McFarland's AMGN Position: Q2 2026 in Review

Penn Davis McFarland reduced its Amgen (AMGN) stake by 0.1% in Q2 2026, selling an estimated $6.16K and leaving 18,748 shares worth $6.79M. The position accounts for 0.6% of the portfolio, ranked #32.

Penn Davis McFarland first reported a position in AMGN in Q3 2016 and has held it in 40 quarters since. 1,335 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Penn Davis McFarland held 18,748 shares of Amgen worth $6.79M as of Q2 2026.
Penn Davis McFarland sold 18 Amgen shares in Q2 2026, an estimated $6.16K.
Amgen made up 0.6% of Penn Davis McFarland's portfolio in Q2 2026, its #32 holding.
Penn Davis McFarland first reported a position in Amgen in Q3 2016 and has held it in 40 quarters since.
1,335 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Penn Davis McFarland's 13F filing for Q2 2026, filed 15 Jul 2026.